Drug Database
J07BX03 covid-19 vaccines
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM VidPrevtyn Beta solution and emulsion for emulsion for injection ▼
- POM Spikevax bivalent Original/Omicron BA.4-5 25 micrograms/25 micrograms dispersion for injection ▼
- POM Spikevax bivalent Original/Omicron BA.4-5 (50 micrograms/50 micrograms)/mL dispersion for injection ▼
- POM Comirnaty Original/Omicron BA.4-5 (15/15 micrograms)/dose dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) ▼
- POM Comirnaty 3 micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) ▼
- POM Spikevax bivalent ▼
- POM Spikevax ▼
- POM Comirnaty Original/Omicron BA.1 (15/15 micrograms)/dose dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) ▼
- POM Nuvaxovid dispersion for injection, COVID-19 Vaccine (recombinant, adjuvanted) ▼
- POM Vaxzevria, suspension for injection, COVID 19 Vaccine (ChAdOx1 S [recombinant]) ▼
- POM Comirnaty 10 micrograms/dose concentrate for dispersion for injection Children 5 to 11 years COVID-19 mRNA Vaccine (nucleoside modified) ▼
- POM Comirnaty 30 micrograms/dose concentrate for dispersion for injection 12+ years COVID-19 mRNA Vaccine (nucleoside modified) ▼
- POM COVID-19 mRNA Vaccine BNT162b2 concentrate for solution for injection (HCP information)
- POM COVID-19 Vaccine Janssen suspension for injection ▼
- POM COVID-19 Vaccine AstraZeneca Reg 174 Information for UK Healthcare Professionals
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).